Navigation Links
New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Date:7/29/2008

Early Clinical Results Unveiled at Society of NeuroInterventional Surgery

Annual Meeting

LAKE TAHOE, Calif., July 29 /PRNewswire/ -- Early clinical results from the US and Argentina reveal that a new minimally invasive procedure successfully eliminates pain and disability caused by lumbar spinal stenosis (LSS), a condition that, in severe form, can cripple sufferers. Announced today at the Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Lake Tahoe, Calif., these early results hold great promise for the nearly 1.5 million patients who are newly diagnosed each year and the neurointerventional practitioners committed to innovating new treatment options as alternatives to traditional surgery.

According to Joshua A. Hirsch, M.D., study presenter and Director of Interventional Neuroradiology/Endovascular Neurosurgery and Chief of Minimally Invasive Spine Surgery at Massachusetts General Hospital, the Minimally Invasive Lumbar Decompression (MILD(TM)) procedure offers patients that previously would have required open surgical treatment an efficacious alternative that can yield the same result with potentially fewer complications and a shorter recovery period. "The beauty of this procedure is that we have the opportunity to restore quality of life to hundreds of thousands of patients who are affected by LSS with an incision far smaller than a dime."

Lumbar stenosis is a narrowing of the spinal canal in the lower back, known as the lumbar area. This narrowing occurs when bone and/or ligament growth restricts the canal, squeezing and irritating the nerves that branch out from the spinal cord. This compression causes patients to experience low back pain, leg fatigue and pain, and, in severe cases, a significant reduced capacity for physical activity, including walking.

Designed to remove the bone and enlarged ligaments that compress the nerve roots, practitioners perform MILD(TM) using a recently-approved FDA device developed by Vertos Medical, Inc. of San Jose, Calif. This proprietary technology enables practitioners to first remove the bone -- known as a Laminotomy -- and then sculpt or thin the ligament.

To date, representatives of Vertos say that 42 patients have undergone the MILD(TM) procedure with no adverse events. Ten patients have been followed under an IRB-approved protocol designed to assess improvement of pain and disability with commonly used measurement instruments, as well as review narcotic intake. At six weeks post-treatment, the mean pain score decreased 90 percent and the mean disability score improved 84 percent, compared to baseline. Additionally, all 10 patients discontinued narcotics use for pain.

Performing the MILD(TM) procedure under radiological guidance, neurointerventional practitioners work through a metal tube -- or working cannula -- inserted through a small incision in the skin directly at the sight of the problem area. Physicians then place the Vertos device inside the cannula, applying it to the relevant bone and ligaments. Because this minimally invasive procedure allows practitioners to remove targeted portions of the bone, MILD(TM) has the advantage of protecting against the destabilization of the spine during the procedure. As with other minimally invasive treatments, patients also benefit from local anesthesia, as well as same- or next-day discharge.

According to Hirsch, like all new treatment options, the MILD(TM) procedure will continue to undergo further study to validate these initial promising results. If the procedure continues to yield the overwhelming success that it has thus far, Hirsch continues, MILD(TM), like other now- established neurointerventional techniques, will become yet another driving force in the advancement of neurointerventional practice. "Compared to other disciplines, our field is still relatively young. But it is revolutionary therapies like this one that are giving neurointerventional practitioners the opportunity to change the entire landscape of patient care."

About SNIS

SNIS members are neurointerventional practitioners with backgrounds in neuroradiology, neurosurgery and neurology that come together in the shared discipline of neurointerventional surgery. Our practitioners specialize in minimally invasive and endovascular procedures to treat stroke, aneurysms, carotid stenosis and spine fractures. Over the past two decades, our physicians have made numerous contributions to the neurosciences including: advancing stroke treatment through catheter based therapy; innovating endovascular coiling for aneurysms; pioneering interventional procedures to treat fractures in the spine; and initiating the first-ever stroke registry to track procedural success in the treatment of acute stroke. More information on SNIS and our members' treatment specialties may be found at http://www.snisonline.org


'/>"/>
SOURCE Society of NeuroInterventional Surgery
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
2. Positive Results Published Using AtriCure Minimally Invasive Products
3. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
4. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
5. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
6. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
7. ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer
8. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
9. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
10. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
11. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
Breaking Medicine Technology:
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/25/2017)... CA (PRWEB) , ... June 25, 2017 , ... FCPX ... media into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different ... film grain for distorted looks, vignettes and blurs to single out subjects, plus much ...
(Date:6/25/2017)... Rosa, CA (PRWEB) , ... June 25, 2017 , ... ... more green and growing foliage and plants, and along with that; a humdinger of ... sensitive allergy sufferers, it also means an increase in misery-causing grass and weed pollen. ...
(Date:6/25/2017)... ... , ... June is Men’s Health Month and the focus is on prostate cancer. ... the U.S. and the third most common cause of cancer related death today; lung cancer ... will be diagnosed with prostate cancer during his lifetime. Those at highest risk ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... ... Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients ... and weekends so that visits to the dentist fit into their patients’ busy ...
Breaking Medicine News(10 mins):